Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4741 of 5804
-
Mood drug trial for pancreatic cancer patients halted early
Symptom relief TerminatedUse of antidepressants for participants with localized pancreatic and periampullary cancer receiving neoadjuvant therapy.
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can water irrigation ease Post-Cancer bowel troubles?
Symptom relief OngoingThe aim of this study is to investigate whether the high-volume transanal irrigation (TAI) performed by the Peristeen Plus® system is superior to the low-volume TAI performed by standard 250ml water enema for the treatment of Low Anterior Resection Syndrome (LARS).
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated Jun 26, 2026 17:43 UTC
-
Can a video replace genetic counseling for cancer patients?
Knowledge-focused Recruiting nowThe overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical pr…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New home blood pressure program aims to tame hypertension remotely
Disease control CompletedHigh blood pressure or hypertension (HTN) is very common and can lead to serious health issues and even death. Medications and lifestyle changes can be used to treat HTN. During the Coronavirus Disease-19 (COVID-19) pandemic, a lot of the care provided by doctors has become virtu…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Scientists probe why some People's blood pressure Doesn't dip at night
Knowledge-focused Recruiting nowThis study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Paxlovid rebound: new study tracks how often COVID returns after treatment
Knowledge-focused CompletedA prospective monitoring study for those individuals treated with Paxlovid
Sponsor: Scripps Translational Science Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Study reveals gaps in heart drug use among obese patients before surgery
Knowledge-focused CompletedPatients with severe obesity frequently exhibit elevated cardiovascular risk. Contributing factors could be inadequate recognition and subsequent management of cardiovascular risk factors, and non-adherence to cardiovascular therapy. This prospective longitudinal cohort study aim…
Sponsor: Universität des Saarlandes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Deaf Babies' brain development under the microscope: new study seeks early warning signs
Knowledge-focused CompletedAmong risk factors of neurodevelopmental disorder is congenital hearing loss. However, congenital deafness is neither necessary nor sufficient for the occurrence of warning signs of neurodevelopmental disorder. The investigative team hypothesizes that the co-occurrence of these t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:05 UTC
-
Can a web program help parents of preemie toddlers?
Knowledge-focused CompletedThe purpose of the study is to test the effects of the ezParent (web-based parent training program) intervention and telephone coaching calls (coach) on parent and child outcomes after 3-, 6-, and 12-months. Parents (n=220) will be randomized using a 2 x 2 factorial design to: (1…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New combo attack on sarcoma: immunotherapy meets precision radiation
Disease control OngoingThis is a pilot study determining the feasibility of combination treatments, pembrolizumab and stereotactic ablative radiotherapy (SBRT) in subjects with soft-tissue sarcoma. These are subjects who have metastatic disease initially, or recurrent or progressive disease that is not…
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill could fight dangerous fungal infections
Disease control TerminatedThis is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis included candidemia. Subjects will receive intravenous echinocandin followed by oral ibrexafungerp (SCY-078) vs intravenous echinocandin followed by oral fluconazole.
Phase: PHASE3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New lupus drug candidate enters first human tests
Disease control OngoingPart 1 : To evaluate the safety and tolerability of a single intravenous (IV) or subcutaneous (SC) dose of KK4277 in healthy Japanese or non-Asian adult males. Part 2 : To evaluate the safety and tolerability of repeated IV or SC administration of KK4277 in patients with Systemi…
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC
-
Can a new drug ease nerve pain in rare heart disease?
Disease control CompletedTo evaluate the efficacy and safety of patisiran in patients with wtATTR amyloidosis and symptomatic polyneuropathy by evaluating the effect on neurologic impairment and quality of life.
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a phone app ease PTSD? small study tests BounceBack now in primary care
Symptom relief CompletedBounceBack Now (BBN) is a self-help, trauma-focused mental health mobile application (app) with automated assessment with treatment guidance and in-app evidence-based treatment support for depression, post-traumatic stress disorder (PTSD), sleep difficulties, and anxiety. BBN con…
Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 26, 2026 15:05 UTC
-
Can a genetic test for eye disease inspire healthier habits?
Knowledge-focused CompletedThe goals of this study are: To assess the impact of genetic testing for Age-related Macular Degeneration (AMD) on lifestyle behaviors as measured by systemic and ocular carotenoid status.
Phase: PHASE2 • Sponsor: Paul S. Bernstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New semaglutide manufacturing process tested in diabetes patients
Disease control CompletedThe study compares two semaglutide medicines and looks at how well they control blood sugar levels, in participants with type 2 diabetes (T2D). Participants will either get the currently available semaglutide or the semaglutide which is produced through a new manufacturing proces…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Breathing tube removal method may reduce oxygen drops after surgery
Knowledge-focused CompletedEvaluation of a postoperative tracheal extubation protocol under positive pressure in accordance with international recommendations. Two arms: the first with "classic" extubation with disconnection of the respirator and the second with extubation without disconnection of the res…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New daily birth control pill shows promise in large trial
Disease control CompletedThis study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The secondary objective of Part A is to evaluate the safety and tolerability of LPRI-CF113. The primary objective of Part B is to evaluate …
Phase: PHASE3 • Sponsor: Insud Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Anti-Inflammatory pill may rewire food choices in overweight people
Knowledge-focused CompletedThe main objective of the FLAIR-i study is to study the causal role of inflammation in affecting effort-based decision making in brain and behaviour in overweight and obesity, by comparing the effect of the anti-inflammatory agent colchicine vs. placebo.
Phase: NA • Sponsor: Donders Centre for Cognitive Neuroimaging • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:11 UTC
-
Protein and exercise may stop muscle loss after bariatric surgery
Disease control Recruiting nowThe aim of this clinical trial is to investigate the effectiveness of collagen, considered a new approach to prevent muscle mass loss after bariatric surgery, and to demonstrate the relationship between this effect and exercise. The key questions it aims to answer are: Does whey…
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC